Alexandre Raphael Wery

Bio

Alexandre-Raphael Wery is a Doctor in medicine from Brussels, Belgium. He specialized in clinical haematology at the Jules Bordet Institute (Université Libre de Bruxelles) and holds a special interest in acute myeloid leukaemia (AML) and cellular therapies such as allogeneic stem cell transplantation.

He received the Henri Tagnon research grant from the Académie Royale de Médecine de Belgique and is currently conducting his research at the Zhang lab (Professor Tian Yi Zhang) to improve disease monitoring in AML, using personalized circulating tumor DNA (ctDNA) profiling, a blood-based approach designed to more sensitively track measurable residual disease (MRD), assess treatment response, refine risk stratification, and detect relapse earlier across the myeloid disease spectrum.

Stanford Advisors

• Tian Yi Zhang, Postdoctoral Faculty Sponsor